Trending Articles

article thumbnail

Bill Gates to accelerate spending at his foundation — then wind it down

STAT

Philanthropist Bill Gates announced Thursday that he will wind down his massive charity in 20 years, doubling spending over that time to accelerate the work it hopes to achieve. Gates made the announcement on the 25th anniversary of the launch of the Gates Foundation, the third-largest player in international philanthropy. He said the foundation would spend $200 billion between now and 2045, when its operations will wind down.

327
327
article thumbnail

Lupin gains USFDA nod for Raltegravir Tablets USP, 600 mg

Express Pharma

Lupin announced that it has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Raltegravir Tablets USP, 600 mg. Raltegravir Tablets are bioequivalent to Isentress HD Tablets, 600 mg of Merck Sharp & Dohme. Lupin is the exclusive first-to-file for this product and is eligible for 180 days of generic drug exclusivity.

102
102
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sanofi and CD&R finalise Opella deal, launching global consumer healthcare giant

Pharmafile

Sanofi and Clayton, Dubilier & Rice (CD&R) have officially closed the sale of a controlling 50% stake in Opella, Sanofis consumer healthcare division, positioning Opella as a new independent leader in the global consumer health space. The deal brings Sanofi approximately 10bn in net cash proceeds. Sanofi retains a 48.2% share in Opella, with Bpifrance […] The post Sanofi and CD&R finalise Opella deal, launching global consumer healthcare giant appeared first on Pharmafile.

100
100
article thumbnail

Prasad’s FDA appointment pressures cell and gene therapy stocks

BioPharma Dive

A vocal opponent of his predecessor Peter Marks, Vinay Prasad will now lead the office tasked with reviewing some genetic medicines, adding more uncertainty to an already struggling field of research.

83
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Patent box tax incentives pharmaceutical innovation

Drug Patent Watch

"The Patent Box Tax Incentive: A Game-Changer for Pharmaceutical Innovation? As the pharmaceutical industry continues to drive groundbreaking research and development, a lesser-known tax incentive has emerged as a key catalyst for innovation. The Patent Box tax regime, introduced in the UK in 2013, has been hailed as a success in fostering a culture of R&D and entrepreneurship.

78

More Trending

article thumbnail

RFK Jr launches database project to explore autism causes

pharmaphorum

A project to use federal databases to identify the "root causes of autism" has been launched by HHS, but there are concerns about its credibility

76
article thumbnail

Novo Nordisk cuts 2025 outlook due to compounding-hit Wegovy demand

Pharmaceutical Technology

Novo Nordisk has cut its sales and profits forecasts for 2025 due to lower demand in the US for blockbuster weight loss and diabetes drugs.

article thumbnail

Three CAR-T therapies forecasted to capture over 70 per cent of T-Cell immunotherapy market in 2025

Express Pharma

T-cell immunotherapies (TCI) are redefining cancer care, with chimeric antigen receptor T-cell (CAR-T) therapies witnessing significant momentum. In 2025, just three drugs- Carvykti by Legend Biotech, Yescarta by Gilead Sciences, and Breyanzi by Bristol-Myers Squibb (BMS) are expected to capture over 70 per cent of the global T-cell immunotherapy market, according to GlobalData.

64
article thumbnail

Viatris’ new form of old pain drug scores in large trials

BioPharma Dive

A version of meloxicam designed to work faster has beat out a placebo in two late-stage studies focused on post-surgical acute pain. Viatris now plans to file for approval this year.

73
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: Compounders lose legal battle with FDA over removal of Eli Lilly’s weight loss drug from a shortage list

STAT

A federal judge has sided with the U.S. Food and Drug Administration over a decision last year to remove two Eli Lilly drugs — the Zepbound weight loss medicine and the Mounjaro diabetes treatment — from a shortages list kept by the agency. The move means that patients will no longer have access to cheaper versions from compounding pharmacies.

article thumbnail

New CBER Director Appointed

PharmaTech

FDA chooses Dr. Vinay Prasad, MD, MPH, a hematologist-oncologist, to lead the Center for Biologics Evaluation and Research at FDA.

59
article thumbnail

Majority of Europeans trust technology to improve healthcare, Johnson & Johnson survey finds

Pharmafile

A global survey by Johnson & Johnson MedTech has revealed that a majority of Europeans are willing to share their health data in exchange for more personalised care signalling growing public trust in the role of technology in healthcare. Conducted between August and September 2024, the survey gathered responses from both the general public […] The post Majority of Europeans trust technology to improve healthcare, Johnson & Johnson survey finds appeared first on Pharmafile.

66
article thumbnail

Roquette restructures company, appoints new leaders following the acquisition of IFF Pharma Solutions

Express Pharma

Roquette, a provider of plant-based ingredients and pharmaceutical excipients for the health and nutrition sectors, announces a new organisation following its acquisition of IFF Pharma Solutions, announced on May 1. The new organisation aims to enhance agility and customer responsiveness. Now with over 11,000 employees, 40 manufacturing sites and a network of global R&D and Innovation Centres, the company aims to expand its global footprint and the diversity of its portfolio.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

GP premises investment must improve pharmacist workspaces, urges PDA

The Pharmacist

New government investment for general practice premises must ensure that pharmacists working in these settings have the facilities they need to do their job properly, the Pharmacists' Defence Association (PDA) has urged. It comes as more than 1,000 GP practices in England will be given funding from the government for quick fix estate upgrades this […] The post GP premises investment must improve pharmacist workspaces, urges PDA appeared first on The Pharmacist.

59
article thumbnail

Recursion cuts nearly half of its pipeline

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, there’s been a lot of discussion lately about how the U.S. can stay competitive in science, biomedical innovation, and drug development. We’ve got several pieces of news relevant to that issue today.

article thumbnail

Gilead’s Entry Inhibitor for Chronic Hepatitis Delta Demonstrates Durable Virologic Suppression Post-Treatment

PharmExec

Results from the Phase III MYR301 trial show that 36% of patients who achieved undetectable hepatitis delta virus levels when treated with bulevirtide maintained suppression for nearly two years.

52
article thumbnail

Landmark UK-India trade deal insufficient for life sciences, says industry body

European Pharmaceutical Review

The UK and India have agreed a major trade deal, however it does not provide sufficient support the UK pharmaceutical industry, according to the Association of the British Pharmaceutical Industry (ABPI). While the UK government considers the agreement to be the UKs largest and most economically significant bilateral trade deal since its EU exit in 2020, the industry body argued that it does not address key areas such as intellectual property protections for innovators within the Indian market.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

FABA, IIL, and ABF launch finishing school programme in Hyderabad

Express Pharma

The Federation of Asian Biotech Associations (FABA), Indian Immunologicals (IIL), and Agri Biotech Foundation (ABF) jointly inaugurated a finishing school programme at the Agri Biotech Foundation campus, Rajendra Nagar, Hyderabad. This programme gap between academic learning and industry readiness in biotechnology, The programme, which will run until June 4, 2025, provides intensive, hands-on training in wet lab facilities, offering real-world experience in microbiology, molecular biology, and c

article thumbnail

Health equity can be a competitive advantage: What pharma leaders need to know

pharmaphorum

As NICE begins to incorporate health equity into drug reimbursement decisions, forward-looking pharmaceutical companies have a chance to lead aligning innovation with access drivers and gaining a competitive edge in a changing global landscape.

article thumbnail

STAT+: Flatiron Health veterans raise $25 million for AI tool to forecast drug toxicity

STAT

In January, San Francisco’s Union Square was bustling with hordes of drug developers and investors, pounding the pavement on their way from meeting to meeting. But Rohan Ganesh, an investor at the VC firm Obvious Ventures, wasn’t among them. He only agreed to hear one company’s pitch during this year’s J.P. Morgan Healthcare Conference.

article thumbnail

FDA grants RMAT status to Opus Genetics’ OPGx-LCA5 gene therapy

Pharmaceutical Technology

The US FDA has granted regenerative medicine advanced therapy (RMAT) designation to Opus Genetics gene therapy OPGx-LCA5

52
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Pharma Marketing Strategies That Actually Drive Results

Pharma Marketing Network

In an era where attention spans are shorter and healthcare stakeholders are increasingly digital-first, executing pharma marketing strategies that truly deliver ROI is both a challenge and a necessity. How do pharmaceutical brands cut through the clutter, earn HCP trust, and engage patients effectively? The answer lies in combining proven fundamentals with innovative tools and omnichannel integration.

52
article thumbnail

Accretion Pharmaceuticals’ IPO to open on May 14 2025; Price band fixed at ₹96-101

Express Pharma

Accretion Pharmaceuticals, an Ahmedabad-headquartered pharmaceuticals manufacturer, announced that its initial public offering (IPO) will open for subscription on Wednesday, May 14, 2025. The anchor portion will be opened on Tuesday, May 13, 2025, and the issue will conclude on Friday, May 16, 2025. The company intends to raise 29.75 crore from the offering and aims to be listed on the NSE Emerge platform.

article thumbnail

Asembia 2025: Digital Health and Biosimilars Shape the Future of Pharmacy

PharmExec

Blake Powers, CEO, medigi, explains how digital tools, AI, and automation are streamlining access to biosimilars and cell and gene therapies, signaling a shift toward more tech-enabled, patient-centric care.

article thumbnail

Elizabeth Holmes rises again — or at least her partner does

STAT

She is serving an 11-year prison sentence for misleading investors and is barred from participating in federal health programs for 90 years. But Elizabeth Holmes’ dream of a diagnostic testing revolution is once again the talk of health care. The emergence of Haemanthus, a company formed by Holmes’ partner, Billy Evans, triggered a mix of shock, anger, and rueful skepticism on Monday, as one of health care’s most infamous frauds morphed into a new form, with fresh capital be

167
167
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Sarepta shares fall amid FDA’s CBER appointment and weak Elevidys sales

Pharmaceutical Technology

Sareptas stock dropped by 26% after the FDA named a vocal critic of its gene therapy programme to lead its biologics division.

52
article thumbnail

Boehringer advances oral therapy for geographic atrophy

pharmaphorum

Boehringer Ingelheim has started a phase 2 trial of a drug that could offer the first oral drug for geographic atrophy, a major cause of sight loss.

59
article thumbnail

We are well-aligned to capitalise on the CDMO opportunity

Express Pharma

India may today account for less than 23 per cent of the pharma CDMO market today but has the potential to grow from $3.5 billion to $25 billion. Dr Abdelaziz Toumi, CEO, Lupin Manufacturing Solutions (LMS), explains to Viveka Roychowdhury how LMS is aligning long-term strategies, repositioning key assets, lining up investments in new modalities and leveraging Indias API ecosystem to capitalise on this opportunity.